Skip to content

Midterm outcomes of penetrating keratoplasty following allogeneic cultured limbal epithelial transplantation in patients with bilateral limbal stem cell deficiency

Midterm outcomes of penetrating keratoplasty following allogeneic cultured limbal epithelial transplantation in patients with bilateral limbal stem cell deficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032536
Enrollment
Unknown
Registered
2020-05-01
Start date
2015-01-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

limbal stem cell deficiency

Interventions

total LSCD caused by bilateral chemical burns:ACLET+PKP

Sponsors

Qingdao Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 64 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for ALCET: 1. Bilateral total LSCD secondary to chemical burns; 2. >=6 months after injury with stable ocular surface; 3. abided by medications as instructed;with regular eyelids, Schirmer test score more than 5mm. Inclusion criteria for PKP: 1. performed approximately 6 months after ALCET; 2. Ocular surface in homeostasis without signs of recurrent LSCD; 3. best corrected visual acuity less than 20/200; 4. ith full-layer corneal stromal opacification, scars, or swelling ;subjective intention of vision improvement.

Exclusion criteria

Exclusion criteria: 1. With severe systemic disease(s) or had contraindications of steroids and immunosuppressants; 2. previous limbal tissue transplantation, ACLET or COMET, or had other intraocular surgeries, like cataract extraction, or anti-glaucoma surgery etc.

Design outcomes

Primary

MeasureTime frame
ocular surface grading score;best corrected visual acuity;persistent epithelial defect;graft rejection;

Secondary

MeasureTime frame
graft endothelial cell density;

Countries

China

Contacts

Public ContactYanling Dong

Qingdao Eye Hospital

yanling1235@126.com+86 13969852284

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026